A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis

A Pacifico; R Daidone; Ketty Peris

doi:10.1111/j.1468-3083.2006.01387.x

A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis

A Pacifico, R Daidone, Ketty Peris

Risultato della ricerca: Contributo in rivista › Articolo in rivista

21 Citazioni (Scopus)

Abstract

Betamethasone valerate (BMV) is a medium-potency corticosteroid commonly used for the treatment of chronic psoriasis. Although occlusion has been shown to enhance the efficacy of BMV treatment, no ready-to-use occlusive BMV formulation is currently approved for the market.

Lingua originale	English
pagine (da-a)	153-157
Numero di pagine	5
Rivista	Journal of the European Academy of Dermatology and Venereology
Volume	20
DOI	https://doi.org/10.1111/j.1468-3083.2006.01387.x
Stato di pubblicazione	Pubblicato - 2006

Keywords

Administration, Cutaneous
Adult
Aged
Betamethasone Valerate
Chemistry, Pharmaceutical
Double-Blind Method
Female
Glucocorticoids
Humans
Male
Middle Aged
Occlusive Dressings
Prospective Studies
Psoriasis
Questionnaires
Severity of Illness Index
Treatment Outcome

Accesso al documento

10.1111/j.1468-3083.2006.01387.x

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{66e7197f01764a099a47f6d2f96d1108,

title = "A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis",

abstract = "Betamethasone valerate (BMV) is a medium-potency corticosteroid commonly used for the treatment of chronic psoriasis. Although occlusion has been shown to enhance the efficacy of BMV treatment, no ready-to-use occlusive BMV formulation is currently approved for the market.",

keywords = "Administration, Cutaneous, Adult, Aged, Betamethasone Valerate, Chemistry, Pharmaceutical, Double-Blind Method, Female, Glucocorticoids, Humans, Male, Middle Aged, Occlusive Dressings, Prospective Studies, Psoriasis, Questionnaires, Severity of Illness Index, Treatment Outcome, Administration, Cutaneous, Adult, Aged, Betamethasone Valerate, Chemistry, Pharmaceutical, Double-Blind Method, Female, Glucocorticoids, Humans, Male, Middle Aged, Occlusive Dressings, Prospective Studies, Psoriasis, Questionnaires, Severity of Illness Index, Treatment Outcome",

author = "A Pacifico and R Daidone and Ketty Peris",

year = "2006",

doi = "10.1111/j.1468-3083.2006.01387.x",

language = "English",

volume = "20",

pages = "153--157",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis

AU - Pacifico, A

AU - Daidone, R

AU - Peris, Ketty

PY - 2006

Y1 - 2006

N2 - Betamethasone valerate (BMV) is a medium-potency corticosteroid commonly used for the treatment of chronic psoriasis. Although occlusion has been shown to enhance the efficacy of BMV treatment, no ready-to-use occlusive BMV formulation is currently approved for the market.

AB - Betamethasone valerate (BMV) is a medium-potency corticosteroid commonly used for the treatment of chronic psoriasis. Although occlusion has been shown to enhance the efficacy of BMV treatment, no ready-to-use occlusive BMV formulation is currently approved for the market.

KW - Administration, Cutaneous

KW - Adult

KW - Aged

KW - Betamethasone Valerate

KW - Chemistry, Pharmaceutical

KW - Double-Blind Method

KW - Female

KW - Glucocorticoids

KW - Humans

KW - Male

KW - Middle Aged

KW - Occlusive Dressings

KW - Prospective Studies

KW - Psoriasis

KW - Questionnaires

KW - Severity of Illness Index

KW - Treatment Outcome

KW - Administration, Cutaneous

KW - Adult

KW - Aged

KW - Betamethasone Valerate

KW - Chemistry, Pharmaceutical

KW - Double-Blind Method

KW - Female

KW - Glucocorticoids

KW - Humans

KW - Male

KW - Middle Aged

KW - Occlusive Dressings

KW - Prospective Studies

KW - Psoriasis

KW - Questionnaires

KW - Severity of Illness Index

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/57609

U2 - 10.1111/j.1468-3083.2006.01387.x

DO - 10.1111/j.1468-3083.2006.01387.x

M3 - Article

SN - 0926-9959

VL - 20

SP - 153

EP - 157

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

ER -

A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo